Clinical Trial Update: Cyclophosphamide in Treating Young Patients With Severe Autoimmune Enteropathy [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating cyclophosphamide in young patients with severe autoimmune enteropathy has completed; results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autoimmune Enteropathy
• Diarrhea
• Gastrointestinal Complications in Children

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)

Snippet

Sponsor: Johns Hopkins University | Conditions: Diarrhea, Gastrointestinal Complications | Phase 2 | Status: COMPLETED | Results posted: 2019-04-16